Clinical trial
Neuromodulation in COVID-19 Patients
NCT04808284 is registered in ClinicalTrials.gov with D'Or Institute for Research and Education as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Neuromodulation in COVID-19 Patients
- Lead sponsor
- D'Or Institute for Research and Education
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 10, 2021
- Completion date
- October 11, 2021
- Enrollment
- 60 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.